Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Hemostatic Powder for the Endoscopic Treatment of Gastrointestinal Bleeding: Evaluation of Efficacy, Feasibility and Rebleeding Predictive Factors Results From a Multicenter Prospective Study Performed in Routine Practice

NCT02595853 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02595853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02595853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Hemostatic Powder for the Endoscopic Treatment of Gastrointestinal Bleeding: Evaluation of Efficacy, Feasibility and Rebleeding Predictive Factors Results From a Multicenter Prospective Study Performed in Routine Practice
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
January 31, 2015
Enrollment
200 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal bleeding